New York: In a clinical trial of children 5 to 11 years old, the Pfizer (PFE.N)/BioNTech Covid-19 vaccine showed 90.7% efficacy against the virus, stated the U.S. drugmaker. After the results, Pfizer and BioNTech claimed that their vaccine rendered a strong immune response in the children.
